Category
Anlotinib
CAS Number
2205042-45-9
Molecular Formula
C₂₃H₂₂FN₃O₃
Molecular Weight
393.4 g/mol.
Synonym

7-((1-Aminocyclopropyl)methoxy)-4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)quinolin-6-ol; 7-[(1-Aminocyclopropyl)methoxy]-4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-Quinolinol; 6-Quinolinol, 7-[(1-aminocyclopropyl)methoxy]-4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]; Anlotinib Impurity B; 6-Quinolinol, 7-[(1-aminocyclopropyl)methoxy]-4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-

Keywords
Pharmaceutical Standards
Intermediates
Fine Chemicals
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Anlotinib Impurity 2 is a high-purity pharmaceutical impurity reference standard associated with the synthesis and analytical evaluation of Anlotinib, a multi-targeted tyrosine kinase inhibitor used in cancer therapy. It has CAS Number of 2205042-45-9, molecular formula of C₂₂H₂₀FN₃O₃, molecular weight of 393.4 g/mol. It is widely utilized in impurity profiling, analytical method development, quality control, and pharmaceutical R&D to detect and monitor Anlotinib-related impurities during API manufacturing. The compound is suitable for HPLC, LC-MS, and NMR analyses, ensuring precise assay results, method validation, and compliance with USP, EP, ICH, and FDA guidelines.

Manasa Life Sciences, headquartered in Hyderabad, India, supplies Anlotinib Impurity 2 as a fully characterized reference standard to pharmaceutical manufacturers, CROs, and research laboratories worldwide. Each batch comes with complete documentation, certified reference material, and Safety Data Sheets, supporting reliable impurity detection and compliance with international pharmacopeial and regulatory standards across Asia, Europe, Africa, the GCC, and the UAE.